Company / Gross Margin
GeneDx Holdings Corp. Gross Margin History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
69.7%
FY2025
5-year range
-11.4% / 69.7%
FY2021-FY2025
Trend
+9.6%
vs FY2024
Sector context
#19 of 91
Health Care
What the data says
GeneDx Holdings Corp.'s gross margin of 69.7% is higher than 79% of companies in the Health Care sector (FY2025). Gross Margin has increased for 3 consecutive years, from -11.4% in FY2022 to 69.7% in FY2025.
Based on SEC 10-K filings.
69.7% in FY2025 with a 5-year CAGR of +67.5%. Top quartile in the Health Care sector.
Improved from 44.4% to 69.7% over the past 2 years.
Health Care sector context is included.
Gross Margin over time
Growth rates
- 3-Year Change
- +81.1pp
- 5-Year Change
- +67.5pp
- 10-Year Change
- -
Sector benchmark
Top 21% in Health CareTop 21% of 91This company 69.7% Sector average 53.8%
▼
+29.6% above sector average
Key checks
Key Insights
- GeneDx Holdings Corp.'s gross margin has grown for 3 consecutive years.
- In FY2025, gross margin increased 9.6% year-over-year.
- Currently 15.9pp above the Health Care sector average.
- Lowest gross margin in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -0.67 (distress zone, below 1.8 threshold)
- Negative profit margin: -17.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 69.7% | +9.6% |
| FY2024 | 63.6% | +43.2% |
| FY2023 | 44.4% | +489.7% |
| FY2022 | -11.4% | -45.8% |
| FY2021 | -7.8% | -448.3% |
| FY2020 | 2.2% | -94.7% |
| FY2019 | 42.2% | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026